Reuters - Video

エディション: US | UK | IN | CN | JP

video

Shire sells cancer drugs to Servier as Takeda circles

2018年 4月 16日 Monday - 01:20

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years.

▲ ストーリーを隠す

ストーリーを表示する

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years.

リンクをコピーするには:URL上で右クリック後「コピー」を選択。モバイル端末では、URLを長押ししてください。

Shire sells cancer drugs to Servier as Takeda circles

2018年 4月 16日 Monday - 01:20